We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Achieve Highly Sensitive Viral Detection with the SARS-CoV-2 NGS Assay - RUO

As SARS-CoV-2 continues to evolve, there is a continued need for research and testing technologies that are better suited to dealing with these novel viruses.

Twist’s hybrid capture system and custom SARS-CoV-2 NGS Assay – RUO, combined with Biotia’s COVID-DX software, represents a powerful new advancement in viral surveillance research.

Download this application focus to learn about:

  • The end-to-end SARS-CoV-2 NGS assay workflow
  • Benefits of hybrid-capture technology and COVID-DX software
  • How target enrichment leads to more even coverage across the entire genome